Anticancer Drugs Course
This course equips oncology professionals with practical skills to master first-line EGFR TKI strategies for EGFR-mutated NSCLC. Learners will manage toxicities effectively, navigate resistance challenges, optimize patient outcomes, and communicate treatment plans clearly using evidence-based approaches.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Gain a practical overview of first-line systemic treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemotherapy. Master drug mechanisms, dosing schedules, toxicity profiles, prevention strategies, resistance mechanisms, second-line therapies, monitoring protocols, and patient communication skills for confident decision-making.
Elevify advantages
Develop skills
- Select EGFR TKI first-line regimens using latest trial evidence.
- Plan imaging, re-biopsy, and liquid biopsy for resistance assessment.
- Match resistance to targeted therapy, chemo, or trial options.
- Prevent and manage EGFR TKI rash, diarrhea, ILD, and cytopenias.
- Counsel patients clearly on goals, side effects, and progression plans.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students say
FAQs
Who is Elevify? How does it work?
Do the courses have certificates?
Are the courses free?
What is the course workload?
What are the courses like?
How do the courses work?
What is the duration of the courses?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course